Analyst Activity – SunTrust Banks Raises Its Price Target On NASDAQ:ADAP – Adaptimmune Therapeutics (NASDAQ:ADAP) to

ME Staff
-
0

Analyst Ratings For NASDAQ:ADAP – Adaptimmune Therapeutics (NASDAQ:ADAP)

Today, SunTrust Banks raised its price target on NASDAQ:ADAP – Adaptimmune Therapeutics (NASDAQ:ADAP) to per share.

Some recent analyst ratings include

  • 5/9/2018-Cowen Reiterated Rating of Buy.
  • 3/16/2018-Leerink Swann initiated coverage with a Buy rating.
  • 3/17/2017-Wells Fargo initiated coverage with a Market Perform ➝ Market Perform rating.
  • 10/24/2016-Bank of America was Downgraded by analysts at Bank of America from a “Neutral ➝ Underperform” rating to a “” rating.

Recent Insider Trading Activity For NASDAQ:ADAP – Adaptimmune Therapeutics (NASDAQ:ADAP)
NASDAQ:ADAP – Adaptimmune Therapeutics (NASDAQ:ADAP) has insider ownership of 24.45% and institutional ownership of 55.89%.

  • On 3/29/2018 Orbimed Advisors Llc, Director, sold 1,048,067 with an average share price of $11.50 per share and the total transaction amounting to $12,052,770.50.
  • On 3/27/2018 Enterprise Associates 14 New, Major Shareholder, bought 6,571,164 with an average share price of $1.92 per share and the total transaction amounting to $12,616,634.88.
  • On 3/26/2018 David M Mott, Director, bought 571,164 with an average share price of $1.90 per share and the total transaction amounting to $1,085,211.60.
  • On 3/23/2018 Enterprise Associates 14 New, Major Shareholder, bought 1,268,508 with an average share price of $1.91 per share and the total transaction amounting to $2,422,850.28.
  • On 3/22/2018 David M Mott, Director, bought 869,574 with an average share price of $1.90 per share and the total transaction amounting to $1,652,190.60.
  • On 3/21/2018 Ravi Viswanathan, Major Shareholder, bought 104,844 with an average share price of $1.81 per share and the total transaction amounting to $189,767.64.
  • On 3/20/2018 Adrian Rawcliffe, CFO, sold 600,000 with an average share price of $1.71 per share and the total transaction amounting to $1,026,000.00.

Recent Trading Activity for NASDAQ:ADAP – Adaptimmune Therapeutics (NASDAQ:ADAP)
Shares of NASDAQ:ADAP – Adaptimmune Therapeutics closed the previous trading session at 14.23 up +0.49 3.57% with 84735 shares trading hands.